Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ambrosch

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Postgraduate Medical Journal|January 1, 1987
Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjectsF Ambrosch, W Frisch-Niggemeyer, P Kremsner, et al.
Lancet (London, England)|May 10, 1986
Boosting properties of recombinant DNA hepatitis B vaccineF Ambrosch, P Kremsner, G Wiedermann, et al.
Postgraduate Medical Journal|January 1, 1987
Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccineG Wiedermann, F Ambrosch, P Kremsner, et al.
Vaccine|January 1, 1994
Study of pertussis vaccines in infants: comparison of response to acellular pertussis DTP vaccines containing 25 micrograms of FHA and either 25 or 8 micrograms of PT with response to whole-cell pertussis DTP vaccineH Vanura, M Just, F Ambrosch, et al.
Vaccine|January 1, 1992
Simultaneous vaccination against hepatitis A and B: results of a controlled studyF Ambrosch, F E André, A Delem, et al.
Vaccine|March 15, 2000
A hepatitis B vaccine formulated with a novel adjuvant systemF Ambrosch, G Wiedermann, M Kundi, et al.
International Archives of Allergy and Applied Immunology|January 1, 1988
Lack of induction of IgE and IgG antibodies to yeast in humans immunized with recombinant hepatitis B vaccinesG Wiedermann, O Scheiner, F Ambrosch, et al.
Journal of Medical Virology|December 1, 1994
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccineF Ambrosch, G Wiedermann, F E André, et al.
Vaccine|September 1, 1987
Multicentre dose range study of a yeast-derived hepatitis B vaccineG Wiedermann, N Scheiermann, P Goubau, et al.
Vaccine|December 1, 1990
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteersG Wiedermann, F Ambrosch, H Kollaritsch, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Postgraduate Medical Journal|January 1, 1987
Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjectsF Ambrosch, W Frisch-Niggemeyer, P Kremsner, et al.
Lancet (London, England)|May 10, 1986
Boosting properties of recombinant DNA hepatitis B vaccineF Ambrosch, P Kremsner, G Wiedermann, et al.
Postgraduate Medical Journal|January 1, 1987
Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccineG Wiedermann, F Ambrosch, P Kremsner, et al.
Vaccine|January 1, 1994
Study of pertussis vaccines in infants: comparison of response to acellular pertussis DTP vaccines containing 25 micrograms of FHA and either 25 or 8 micrograms of PT with response to whole-cell pertussis DTP vaccineH Vanura, M Just, F Ambrosch, et al.
Vaccine|January 1, 1992
Simultaneous vaccination against hepatitis A and B: results of a controlled studyF Ambrosch, F E André, A Delem, et al.
Vaccine|March 15, 2000
A hepatitis B vaccine formulated with a novel adjuvant systemF Ambrosch, G Wiedermann, M Kundi, et al.
International Archives of Allergy and Applied Immunology|January 1, 1988
Lack of induction of IgE and IgG antibodies to yeast in humans immunized with recombinant hepatitis B vaccinesG Wiedermann, O Scheiner, F Ambrosch, et al.
Journal of Medical Virology|December 1, 1994
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccineF Ambrosch, G Wiedermann, F E André, et al.
Vaccine|September 1, 1987
Multicentre dose range study of a yeast-derived hepatitis B vaccineG Wiedermann, N Scheiermann, P Goubau, et al.
Vaccine|December 1, 1990
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteersG Wiedermann, F Ambrosch, H Kollaritsch, et al.
Pageof 8